WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy

StatusCompleted
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 4 more changesShow less
    • Primary completion date changed from estimate of Dec 2026 to Oct 2, 2026
    • Enrollment target: estimated 50 to confirmed 52
    • Eligibility criteria expanded, about 15 words
    • Site details revised
  2. Primary completion pushed from Jun 2026 to Dec 2026
    • Study completion pushed from Jun 2027 to Dec 2027
    v23
  3. Study sites: 2 to 1v22
  4. Primary completion date: Dec 2025 to Jun 2026
    • Study completion date: Dec 2026 to Jun 2027
    v21
  5. Primary completion date: Jul 2025 to Dec 2025
    • Study completion date: Jul 2026 to Dec 2026
    v20
Show 18 earlier versionsHide 18 earlier versions
  1. Primary completion date: Jan 2025 to Jul 2025
    • Study completion date: Jan 2026 to Jul 2026
    • Site contacts updated at 1 of 2 sites
    v19
  2. Site contacts updated at 2 of 2 sitesv18
  3. Site contacts updated at 1 of 2 sitesv17
  4. 2 versions Re-verified since Oct 5, 2023, no change to tracked fieldsv15-v16
  5. Study sites: 1 to 2v14
  6. Primary completion date: Jan 2023 to Jan 2025
    • Study completion date: Jan 2024 to Jan 2026
    v13
  7. 3 versions Re-verified since Feb 23, 2022, no change to tracked fieldsv10-v12
  8. Site contact updatedv9
  9. Site contact updatedv8
  10. Primary completion date: Jan 2022 to Jan 2023
    • Study completion date: Jan 2023 to Jan 2024
    v7
  11. Site contact updatedv6
  12. Eligibility criteria expanded, about 8 words
    • Site contact updated
    v5
  13. Study description revisedv4
  14. Re-verified, no change to tracked fieldsv3
  15. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Feb 2019 to Apr 22, 2019
    • Site details revised
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a randomized control trial testing the effect of walnut supplementation on prostate cancer progression in 50 men with biopsy confirmed prostate cancer and planning to undergo RP. Patients consented to the study will be randomly assigned to either continue their usual diets (control arm) or to the walnut arm for 4-10 weeks depending on the window between their consent date and the date for RP.
Trial Details
NCT Number NCT03824652
Lead Sponsor Stephen Freedland
Collaborators: California Walnut Commission
Conditions
(from sponsor)		 Prostate Cancer
Related terms Prostatic Neoplasms
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov